Holen Sie sich die Stockscreener-App
8.01
2.67%
-0.22
Vorhandelsmarkt:
8.11
0.10
+1.25%
Schlusskurs vom Vortag:
$8.23
Offen:
$8.23
24-Stunden-Volumen:
184.93K
Relative Volume:
0.15
Marktkapitalisierung:
$535.65M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-103.21M
KGV:
-1.7413
EPS:
-4.6001
Netto-Cashflow:
$-26.70M
1W Leistung:
+0.12%
1M Leistung:
+33.28%
6M Leistung:
+149.53%
1J Leistung:
+1.14%
1-Tages-Spanne:
$7.75
$8.29
1-Wochen-Bereich:
$7.75
$8.49
52-Wochen-Spanne:
$2.65
$11.14
Engene Holdings Inc Stock (ENGN) Company Profile
Firmenname
Engene Holdings Inc
Sektor
Branche
Telefon
(514) 332-4888
Adresse
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
Vergleichen Sie ENGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENGN
Engene Holdings Inc
|
8.01 | 550.36M | 0 | -103.21M | -26.70M | -4.6001 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-02-18 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-14 | Herabstufung | UBS | Buy → Neutral |
| 2024-12-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-11-27 | Eingeleitet | Raymond James | Outperform |
| 2024-11-18 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-08-28 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-04-15 | Eingeleitet | Guggenheim | Buy |
| 2024-03-28 | Eingeleitet | UBS | Buy |
| 2024-03-08 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-20 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Engene Holdings Inc Aktie (ENGN) Neueste Nachrichten
Market Recap: Can enGene Holdings Inc Equity Warrant stock attract ESG capital inflowsQuarterly Earnings Summary & Smart Money Movement Alerts - BỘ NỘI VỤ
enGene’s Detalimogene Chosen for FDA Manufacturing Pilot Program - TipRanks
EnGene Holdings Inc (ENGN) surging after positive phase 2 LEGEND trial - MSN
enGene Holdings Inc (ENGN) Surging After Positive Phase 2 LEGEND Trial - Finviz
How enGene Holdings Inc. stock performs in rate cut cyclesJuly 2025 Rallies & Long Hold Capital Preservation Plans - Newser
H.C. Wainwright maintains Buy rating on Engene stock as detalimogene joins FDA pilot program By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Buy rating on Engene stock as detalimogene joins FDA pilot program - Investing.com Nigeria
Franklin Resources Inc. Sells 136,866 Shares of enGene Holdings Inc. $ENGN - MarketBeat
9 Best Up and Coming Canadian Stocks to Buy - Insider Monkey
FDA selects enGene’s bladder cancer therapy for development program By Investing.com - Investing.com Australia
enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readines - pharmiweb.com
enGene stock rises after FDA selects bladder cancer therapy for CMC pilot program - Investing.com Nigeria
Engene's detalimogene selected for FDA manufacturing pilot program to support manufacturing readiness - marketscreener.com
enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness - Yahoo Finance
What valuation multiples suggest for enGene Holdings Inc. Equity Warrant stockEarnings Performance Report & Risk Managed Investment Entry Signals - Newser
Can enGene Holdings Inc. Equity Warrant stock attract ESG capital inflowsForecast Cut & AI Optimized Trading Strategy Guides - moha.gov.vn
enGene Holdings Inc Stock Analysis and ForecastHealthcare Stock Analysis & Learn the Secrets of Pro Traders - earlytimes.in
enGene (NASDAQ:ENGN) Trading Up 6.9%Should You Buy? - MarketBeat
enGene Holdings Prices $130 Million Public Offering to Advance Genetic Medicine Programs - MSN
enGene to Present at Piper Sandler Healthcare Conference - TipRanks
enGene to Present at the Piper Sandler 37th Annual Healthcare Conference - Markets Financial Content
PERCEPTIVE ADVISORS LLC's Strategic Acquisition in enGene Holdings Inc. - GuruFocus
PERCEPTIVE ADVISORS LLC's Strategic Acquisition in enGene Holdin - GuruFocus
What drives enGene Holdings Inc Equity Warrant stock priceDebt-to-Equity Ratio Analysis & High Return Trading Ideas - earlytimes.in
enGene Holdings Inc. (ENGN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is enGene Holdings Inc. stock a dividend growth opportunityBuy Signal & Momentum Based Trading Ideas - newser.com
How enGene Holdings Inc. Equity Warrant stock reacts to inflationary pressuresTrade Performance Summary & Growth Focused Entry Point Reports - newser.com
How enGene Holdings Inc. stock compares to growth peersGap Down & Stock Timing and Entry Methods - newser.com
enGene Holdings Inc. (S0N.F) stock price, news, quote and history - Yahoo Finance UK
Is a relief rally coming for enGene Holdings Inc. holders2025 Institutional Moves & Weekly High Return Stock Forecasts - newser.com
Is enGene Holdings Inc. Equity Warrant trending in predictive chart modelsPortfolio Update Report & Breakout Confirmation Trade Signals - newser.com
Is enGene Holdings Inc. Equity Warrant stock bottoming out2025 Top Decliners & Daily Entry Point Alerts - newser.com
Multi asset correlation models including enGene Holdings Inc. Equity WarrantWeekly Trade Recap & Verified Momentum Watchlists - newser.com
How institutional buying supports enGene Holdings Inc. stockQuarterly Investment Review & Safe Entry Trade Reports - newser.com
ENGN: Non-viral gene therapy for NMIBC achieves 62% six-month CR rate, targeting 2027 approval - TradingView
Is enGene Holdings Inc. Equity Warrant stock undervalued vs historical averages2025 Price Targets & Weekly High Return Opportunities - newser.com
enGene Holdings (ENGN) Price Target Increased by 10.59% to 24.20 - Nasdaq
Finanzdaten der Engene Holdings Inc-Aktie (ENGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):